Industries We Serve with Our Market Access, Quality Compliance & Regulatory Affairs Consulting Services

Cisema provides trusted regulatory affairs consulting services to help companies succeed across the Asia Pacific region. With deep expertise in China and the Hong Kong SAR, and expanding support across Southeast Asia and Taiwan, we work with clients in diverse regulatory environments. Backed by decades of experience in regulatory affairs consulting, our team of regulatory experts delivers comprehensive regulatory services, providing end-to-end support for compliance and approvals. We have a proven track record of achieving successful regulatory outcomes for medical devices, IVDs, pharmaceuticals, cosmetics, health products, consumer goods, and industrial products. Our expert guidance ensures smooth market entry, regulatory compliance, and long-term success in one of the world’s most dynamic regions.

Two men in business suits sitting at a table engaged in a meeting with a third person.
Regulatory submissions

Industries We Serve

We support companies in over 16 regulated industries, with a focus on streamlining compliance and approvals for our clients. We help them meet the evolving regulatory landscape and compliance requirements, accelerate approvals, and maintain product quality throughout the lifecycle. For each industry, we develop a tailored regulatory strategy and identify the optimal regulatory pathway to ensure efficient progression through approval stages and reduce risks.

Medical Devices

We assist manufacturers with product registration, clinical trials, post-market surveillance, quality control, and the implementation of quality management systems. As well as inspection and sourcing services, in China, Hong Kong and Taiwan and across Southeast Asia.

Learn more

In Vitro Diagnostics (IVDs)

Our team helps IVD companies navigate rigorous clinical validation, registration, and post-market requirements, ensuring compliance with the latest regulatory and clinical guidelines. We also deliver quality control, inspection, and sourcing services across China, Hong Kong, Taiwan and Southeast Asia.

Learn more

Pharmaceuticals

From early development through to commercialization, we support drug manufacturers throughout the entire drug development process, providing strategic guidance, submission support, and GMP alignment for success across Asia Pacific.Our team has extensive expertise in the preparation and submission of drug applications, including ANDAs and NDAs, ensuring regulatory compliance and smooth interactions with agencies.

Learn more

Biotech

We provide regulatory guidance for biotech innovators across Asia Pacific, supporting clinical trial design, biosafety clearance, import licensing, and alignment with regulators' expectations.

Learn more

Cosmetics & Ingredients

We support cosmetic and ingredient manufacturers throughout the full product lifecycle in China and Taiwan from pre-registration or notification to post-market. We are your “Responsible Person” and ensure quality compliance with Chinese and Taiwanese regulations, assisting in preparation for NMPA and TFDA audits as required.

Learn more

Health Foods & Supplements

We handle regulatory strategies, raw material approvals, testing, and registrations for dietary supplements and health foods. Our team ensures quality compliance and smooth market entry.

Learn more

Veterinary Drugs & Pet Food

We support MARA interactions, registration, licensing, and testing for pet foods and veterinary medicinal products entering the Chinese market.

Learn more

Industrial Goods & Consumer Products

We help you get your products on the market faster, from electronics and toys to machinery, telecom, and automotive parts. Our team manages CCC, HAF 604, CML, CEL, RoHS, NAL, SRRC, and more. From testing and documentation to renewals and authority approvals, we streamline every step to ensure full compliance with China’s regulations.

Learn more

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

Latest Insights

View More

China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 

China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

May 8, 2026
China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 
A young Asian woman in understated casual clothing holding a single unbranded boxed hair dye product slightly angled toward her as she studies the ingredient panel.

Hong Kong Launches Primary Evaluation Phase 1 for NDAs

Hong Kong introduces Primary Evaluation Phase 1 for NDAs, requiring pathway selection across 3 routes and reshaping drug registration strategy.

May 6, 2026
Hong Kong Launches Primary Evaluation Phase 1 for NDAs
A single Asian scientist in their 30s wearing a lab coat, safety glasses, and nitrile gloves seated at a tidy bench in a modern pharmaceutical laboratory in Hong Kong, calmly reviewing a few printed documents while referencing a simple laptop screen

Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138

Hong Kong confirms injectable products are generally classified as pharmaceutical products under Cap. 138, impacting medical aesthetics and borderline products

May 8, 2026
Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138
Minimalist, well-lit medical aesthetics clinic in Hong Kong. An Asian female doctor in a simple white coat and disposable gloves sits beside a female patient, holding a single unbranded prefilled syringe at chest level.

China April 2026 Reforms Reshape Drug Approval, Pricing, & Access

The reforms introduce new drug pricing rules, clarified conditional approval procedures, and tiered care measures.

May 8, 2026
China April 2026 Reforms Reshape Drug Approval, Pricing, & Access
Chinese scientists gathered around a bottle of medicine

Taiwan Abolishes Legacy Cosmetics Review Fees

TFDA eliminates legacy cosmetics review fees, reducing compliance costs for foreign companies.

May 5, 2026
Taiwan Abolishes Legacy Cosmetics Review Fees
Team reviews cosmetics documents for regulatory compliance and market access in Taiwan

CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies

CMDE maps 275 guideline updates, tightening requirements and giving manufacturers early visibility for planning and compliance.

May 5, 2026
CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies
dermatology treatment room in a modern Chinese hospital, medium shot: a licensed clinician in medical scrubs and protective eyewear performing a laser skin procedure using a professional Nd:YAG laser system
Previous
Previous

Get in Touch with Our Regulatory Affairs Experts

And discover how we can support you across your various projects in Asia Pacific.

Request Proposal